GlassScriptPhysician profile
Jason Richard Pingel
NPI 1063449189
$243,924.95
in general payments reported to CMS, 2019-2025
23 companies · $953 in 2025
The $953 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $27K · 2021: $42K · 2022: $99K · 2023: $39K · 2024: $538 · 2025: $953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Travel and Lodging: $5,398 · Food and Beverage: $3,795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31,450.00 |
| Travel and Lodging | $5,397.89 |
| Food and Beverage | $3,794.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $238,599.59 | 2019-2025 | Acuvue |
| Johnson and Johnson International | $2,025.00 | 2020-2022 | |
| Alcon Vision LLC | $557.87 | 2019-2025 | Precision7, Total30, Tryptyr |
| Allergan, INC. | $407.63 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $260.09 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Abbvie INC. | $254.92 | 2022-2023 | |
| Sun Pharmaceutical Industries INC. | $218.45 | 2019-2024 | Cequa |
| Novartis Pharmaceuticals Corporation | $192.39 | 2021-2022 | |
| Dompe US, INC. | $181.74 | 2022-2025 | Oxervate |
| Abb Con-Cise Optical Group LLC | $162.82 | 2019-2024 | Spectacle Lenses, Contact Lens |
| Rxsight INC | $152.39 | 2023-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Ani Pharmaceuticals, INC. | $151.37 | 2025 | Purified Cortrophin Gel |
| Sight Sciences, INC. | $151.03 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $120.81 | 2019 | |
| Aerie Pharmaceuticals, INC. | $114.72 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $113.76 | 2025 | |
| Mallinckrodt Hospital Products INC. | $102.46 | 2024 | Acthar |
| Glaukos Corporation | $73.13 | 2020-2022 | |
| Plexus Optix, INC. | $20.00 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Coopervision INC. | $14.35 | 2023 | Myday Contact Lens |
| Kala Pharmaceuticals, INC. | $13.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Pingel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.